Nodular conjunctivitis as a novel ocular manifestation of canine sterile granuloma/pyogranuloma syndrome. [PDF]
Sypniewska A, Ziółkowska N.
europepmc +1 more source
ABSTRACT The approval of baricitinib and ritlecitinib for alopecia areata (AA) marks the beginning of the Janus kinase (JAK) inhibitor era in AA treatment. Tofacitinib, a first‐generation JAK1/3 inhibitor, has theoretical potential to treat AA; however, real‐world evidence, particularly on comparative outcomes across patient subgroups and patient ...
Yifan Jin +7 more
wiley +1 more source
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study
This study evaluated long‐term safety and efficacy in patients with moderate‐to‐severe atopic dermatitis. Patients with and without previous nemolizumab experience received nemolizumab 30 mg Q4W plus TCS/TCI. Nemolizumab was well‐tolerated through 104 weeks with clinically meaningful improvements in disease signs and symptoms.
Matthias Augustin +24 more
wiley +1 more source
Viral mechanisms, tropism, and clinical relevance regarding the ophthalmic manifestations of SARS-CoV-2 infection. [PDF]
González S +5 more
europepmc +1 more source
Dermatologic toxicity occurring during anti-EGFR monoclonal inhibitor therapy in patients with metastatic colorectal cancer: A systematic review [PDF]
Anadkat, Milan +5 more
core +1 more source
Efficacy of up to 4 years of tralokinumab in adults with moderate‐to‐severe atopic dermatitis
AD is a relapsing and remitting skin disease often requiring long‐term treatment. We assessed the long‐term efficacy of tralokinumab in adults with moderate‐to‐severe AD consistently treated for up to 4 years. Treatment with tralokinumab plus optional TCS/TCI provided substantial improvements in AD signs and symptoms, and these improvements were ...
Melinda Gooderham +13 more
wiley +1 more source
Clinical characteristics and management of dupilumab-associated ocular surface disease in Japan. [PDF]
Shoji J, Ebihara N.
europepmc +1 more source
ABSTRACT Radiotherapy for the treatment of sinonasal tumors in dogs is generally well tolerated, but the range of long‐term adverse effects remains poorly understood. In people receiving radiation for head and neck tumors, existing dental disease is a predisposing factor for radiation‐induced oral complications that can lead to worsening periodontal ...
Erin Paul‐Stewart +4 more
wiley +1 more source
Tear Film Osmolarity in Horses With Bacterial Conjunctivitis. [PDF]
Saberinia A, Ozmaei S, Anoushepour A.
europepmc +1 more source

